Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulant Prophylaxis/Therapy”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Large-scale testing (Phase 3)Looking for participantsNCT07012629
What this trial is testing

A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

Who this might be right for
Covert Brain Infarction
Aarhus University Hospital 1,652
Testing effectiveness (Phase 2)Ended earlyNCT04106700
What this trial is testing

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Who this might be right for
Venous Thromboembolism
Instituto de Investigacion Sanitaria La Fe 60
Testing effectiveness (Phase 2)Study completedNCT00994292
What this trial is testing

Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes

Who this might be right for
Acute Coronary Syndrome
Astellas Pharma Europe B.V. 1,276
Not applicableStudy completedNCT02597920
What this trial is testing

Patient Convenience Study

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,852
Post-approval studies (Phase 4)UnknownNCT00699465
What this trial is testing

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage
University of Oulu 320
Large-scale testing (Phase 3)Study completedNCT02815670
What this trial is testing

Reversal Dabigatran Anticoagulant Effect With Idarucizumab

Who this might be right for
Hemorrhage
Boehringer Ingelheim 1
Not applicableStudy completedNCT02684981
What this trial is testing

Patient Convenience Study (RE-SONANCE)

Who this might be right for
Atrial FibrillationStroke
Boehringer Ingelheim 9,472
Not applicableStudy completedNCT01947998
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 50,299
Not applicableLooking for participantsNCT05900414
What this trial is testing

RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
University of Calgary 60
Large-scale testing (Phase 3)Study completedNCT05185804
What this trial is testing

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

Who this might be right for
COVID-19Venous Thromboembolism
PharmaDiall Ltd. 399
Post-approval studies (Phase 4)Study completedNCT04479579
What this trial is testing

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Who this might be right for
Neoplasms MalignantSurgeryVenous Thromboembolism+2 more
McMaster University 53
Testing effectiveness (Phase 2)Study completedNCT00684307
What this trial is testing

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
AstraZeneca 1,084
Post-approval studies (Phase 4)UnknownNCT06020560
What this trial is testing

Study of Low Molecular Weight Heparins

Who this might be right for
AnticoagulantVenous ThromboembolismProphylaxis+1 more
Herlev Hospital 65,000
Testing effectiveness (Phase 2)Study completedNCT00320255
What this trial is testing

Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Who this might be right for
ThrombosisCancerPulmonary Embolism
Bristol-Myers Squibb 130
Not applicableStudy completedNCT01947959
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 665,533
Testing effectiveness (Phase 2)Study completedNCT00119457
What this trial is testing

Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

Who this might be right for
Venous ThromboembolismEmbolism and ThrombosisHip Fractures
vTv Therapeutics 300
Not applicableUnknownNCT01101256
What this trial is testing

Determination of Residual Anticoagulatory Effects of Fondaparinux

Who this might be right for
Anticoagulant Prophylaxis/Therapy
Johann Wolfgang Goethe University Hospital 110
Large-scale testing (Phase 3)Study completedNCT02801669
What this trial is testing

Study of DU-176b Aged 80 Years or Older

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Co., Ltd. 984
Not applicableStudy completedNCT03854149
What this trial is testing

Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study

Who this might be right for
Congenital Heart DiseaseAtrial ArrhythmiaThromboembolism+1 more
AHEPA University Hospital 218
Not applicableStudy completedNCT02559232
What this trial is testing

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 247
Load More Results